Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - meropenem as trihydrate - powder for solution for injection - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem - meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - meropenem as trihydrate - powder for solution for injection - meropenem as trihydrate 1000 mg/vial - meropenem - meropenem - meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - pneumonias and nosocomial pneumonias. - pulmonary infections in patients with cystic fibrosis. - urinary tract infections. - intra-abdominal infections. - gynecological infections such as endometritis and pelvic inflammatory disease. - skin and skin structure infections. - meningitis. - septicemia. meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. there is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - meropenem, quantity: 500 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: community acquired lower respiratory tract infection; hospital acquired lower respiratory tract infection; complicated urinary tract infection; febrile neutropenia; intra-abdominal and gynaecological (poly microbial) infections; complicated skin and skin structure infections; meningitis; septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - meropenem, quantity: 1 g - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: community acquired lower respiratory tract infection; hospital acquired lower respiratory tract infection; complicated urinary tract infection; febrile neutropenia; intra-abdominal and gynaecological (poly microbial) infections; complicated skin and skin structure infections; meningitis; septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - meropenem trihydrate, quantity: 570.78 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:. - community acquired lower respiratory tract infection. - hospital acquired lower respiratory tract infection. - complicated urinary tract infection. - febrile neutropenia . - intra-abdominal and gynaecological (poly microbial) infections. - complicated skin and skin structure infections. - meningitis. - septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - meropenem trihydrate, quantity: 1.1415 g - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:. - community acquired lower respiratory tract infection. - hospital acquired lower respiratory tract infection. - complicated urinary tract infection. - febrile neutropenia . - intra-abdominal and gynaecological (poly microbial) infections. - complicated skin and skin structure infections. - meningitis. - septicaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - meropenem trihydrate 1140mg equivalent to meropenem 1000 mg - powder for injection - 1000 mg - active: meropenem trihydrate 1140mg equivalent to meropenem 1000 mg excipient: sodium bicarbonate - meropenem actavis is indicated for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: - lower respiratory tract infections - urinary tract infections, including complicated infections - intra-abdominal infections - gynaecological infections, including postpartum infections - skin and skin structure infections - meningitis - septicaemia - empiric treatment, including initial monotherapy, for presumed bacterial infections in host compromised, neutropenic patients. because of its broad spectrum of bactericidal activity against gram-positive and gram-negative aerobicand anaerobic bacteria, meropenem actavis is effective for the treatment of polymicrobial infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - meropenem trihydrate 570mg equivalent to meropenem 500 mg - powder for injection - 500 mg - active: meropenem trihydrate 570mg equivalent to meropenem 500 mg excipient: sodium bicarbonate - meropenem actavis is indicated for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: - lower respiratory tract infections - urinary tract infections, including complicated infections - intra-abdominal infections - gynaecological infections, including postpartum infections - skin and skin structure infections - meningitis - septicaemia - empiric treatment, including initial monotherapy, for presumed bacterial infections in host compromised, neutropenic patients. because of its broad spectrum of bactericidal activity against gram-positive and gram-negative aerobicand anaerobic bacteria, meropenem actavis is effective for the treatment of polymicrobial infections.

Philippines - English - FDA (Food And Drug Administration)

hospira philippines, inc. - meropenem (as trihydrate) - powde for injection / infusion - 1g

Philippines - English - FDA (Food And Drug Administration)

stangen pharmaceuticals philippines inc. - meropenem (as trihydrate) - powder for solution for i.v. injection - 500mg